I like Nader a lot; there is nobody else I'd prefe

I like Nader a lot; there is nobody else I'd prefer to have in control of share issuances and capital raises, the man rescued LLMab from the trash heap, he understands the molecule and significance to Human Health writ large, and he understands what full commercialization is worth.

He isn't easy to understand at times, some because of accent (not so much for me, but that's going to vary widely by individual), some because of syntax.. word choice, sentence structure.. those matter and flipping things around creates confusion.

I'm ambivalent about who the spokesperson is because I DGAF about the short term PPS.. but it's an absolute fact that, even for someone who the accent doesn't present issues with, the syntax still presents communication issues.

I understand "LLMab binds to CCR5" clearly enough, though.